BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28554573)

  • 1. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Cao L; Sun PL; Yao M; Chen S; Gao H
    Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
    Paquette C; Mills AM; Stoler MH
    Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
    Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
    Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
    Clark JL; Lu D; Kalir T; Liu Y
    Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus DNA, HPV L1 capsid protein and p16
    Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.
    Huang EC; Tomic MM; Hanamornroongruang S; Meserve EE; Herfs M; Crum CP
    Mod Pathol; 2016 Dec; 29(12):1501-1510. PubMed ID: 27515495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Human Papillomavirus Capsid Protein L1 and p16 in the Assessment and Accurate Classification of Anal Squamous Intraepithelial Lesions.
    Patil DT; Yang B
    Am J Clin Pathol; 2015 Jul; 144(1):113-21. PubMed ID: 26071469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
    Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
    Hong SA; Yoo SH; Choi J; Robboy SJ; Kim KR
    Arch Pathol Lab Med; 2018 Aug; 142(8):973-981. PubMed ID: 29652189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
    Mills AM; Paquette C; Terzic T; Castle PE; Stoler MH
    Am J Surg Pathol; 2017 Feb; 41(2):143-152. PubMed ID: 27680604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
    Umphress B; Sanchez B; Paintal A; Nayar R; Maniar KP
    Am J Surg Pathol; 2018 Apr; 42(4):479-484. PubMed ID: 29438168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
    Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
    Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
    Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R; Li X; Qian M; Niu J; You Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.